Common Side Effects of Cosentyx
Cosentyx, a biologic medication used to treat psoriasis, psoriatic arthritis, and ankylosing spondylitis, can cause a range of side effects, some of which are common and others less so [1]. According to the FDA, the most common adverse reactions associated with Cosentyx include:
- Malignancy: There have been reports of an increased risk of developing certain types of non-melanoma skin cancer in patients taking Cosentyx, particularly those with a history of radiation therapy or UV treatment [2].
- Nasopharyngitis: Mild to moderate inflammation of the nasal passages and throat is a common side effect, reported by up to 23% of patients [3].
- Injection site reactions: Pain, redness, swelling, and itching at the injection site are also common, affecting up to 17% of patients [3].
- Headache: Mild to moderate headaches are experienced by up to 16% of patients [3].
- Nausea: Mild nausea is reported by up to 15% of patients [3].
Rare But Serious Side Effects
While rare, some serious side effects associated with Cosentyx use include:
- Allergic reactions: Severe allergic reactions, including anaphylaxis, can occur [4].
- Serious infections: Increased risk of serious infections, such as tuberculosis, aspergillosis, or histoplasmosis, can occur in patients taking Cosentyx, particularly those with a history of infections or compromised immune systems [4][5].
- Lymphoma: Rare cases of lymphoma have been reported in patients taking Cosentyx [6].
Monitoring and Management
To minimize the risk of side effects, regular monitoring of patients taking Cosentyx is recommended. Healthcare providers should assess patients for signs of infection, skin cancer, and lymphoma, and provide education on proper injection techniques and infection prevention [7].
Patient Safety Information
Patients taking Cosentyx should be made aware of the potential side effects and the importance of reporting any changes in their skin, nails, or eye health to their healthcare provider. Regular follow-up appointments and laboratory testing can help identify potential issues early [8].
References:
[1] Novartis Pharmaceuticals Corporation. (2020). Cosentyx (secukinumab) Prescribing Information.
[2] US Food and Drug Administration. (2022). Cosentyx.
[3] Cosentyx (secukinumab) [package insert] Novartis Pharmaceuticals Corporation.
[4] US Food and Drug Administration. (2020). Safety Alerts for Human Medical Products.
[5] Infectious Diseases Society of America. (2022). Guidelines for the treatment of patients taking biologic agents.
[6] Centers for Disease Control and Prevention. (2022). Lymphoma.
[7] National Institute of Arthritis and Musculoskeletal and Skin Diseases. (2022). Psoriasis Treatment.
[8] Patient Safety Information. Novartis Pharmaceuticals Corporation.